Growing Need for Learning Disability Treatment Options
10th January 2008
A growing body of evidence suggests that essential fatty acids can play a role in managing learning and behavioural conditions such as ADHD. A clinical trial in Australia showed that almost 50% of ADHD children, aged 7-12, taking Equazen eye q for 30 weeks showed a significant reduction in their parent-rated behavioural symptoms(3). The EPA (eicosapentaenoic acid), DHA (Docasahexaenoic Acid) and GLA (Gamma Linolenic Acid): long chain polyunsaturated essential fatty acids in Equazen eye q are thought to play an important role in brain development and function.
http://www.itnews.it/2008/0109131602587/growing-need-for-learning-disability-treatment-options.html
Posted in Learning Disabilities | No Comments »
